A Unique Solution for Patient Eligibility Review

Judi for Remote Monitoring and Medrio EDC Integration

Navigating the Post-Capture Era of Clinical Trials

Clinical-stage biotech combines Judi for Eligibility and Adjudication on pivotal Phase 2 CAR-T oncology trial

International biopharma sponsor and partner CRO maximize flexibility of Judi for DSMB for Phase 2 multinational clinical program

U.S.-based biopharma leverages scalability of Judi for Imaging on three concurrent pulmonary oncology trials

U.S.-based medical device sponsor and partner CRO leverage flexibility of Judi for DSMB for cardiovascular implant trial

Harnessing AI for Clinical Trial Workflow Management

European-based biopharma and partner CRO employ dynamic controls of Judi for Adjudication and Site & User Qualification for rare disease immunotherapy trial

European-based pharmaceutical company and CRO utilize dexterity of Judi for Eligibility on pivotal phase 3, novel psychedelic clinical program

Multinational biopharmaceutical company engages innovation of Judi for Adjudication for concurrent Phase 3 clinical trials with over 900 patients, and 150 endpoints

Global biopharma sponsor selects dynamic innovation of Judi for Imaging on critical Phase 3 Oncology trial with over 170 sites and 4000 endpoints

Prominent medical device company leverages the flexibility of Judi for Imaging and Eligibility on pivotal phase 3 medical implant trial

AG Mednet Receives Frost & Sullivan's 2023 Global Customer Value Leadership Award

Addressing Regulatory Challenges

Judi Accelerates Clinical Trials